In low-grade astrocytomas, AQP1 immunoreactivity was present mostly in the plasma membrane, whereas in high-grade astrocytomas, massively-upregulated AQP1 was also distributed throughout the cytoplasm [70]. This evidence concerns the gene AQP1 and astrocytoma (excluding glioblastoma).